Signaling Pathways - voltage-gated chloride channels - GPR35 - VEGFR - Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
清除全部
-
C3342 MAZ51Target: VEGFRSummary: VEGFR3拮抗剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5864 Fruquintinib(HMPL-013)中文名: 呋喹替尼Target: VEGFRSummary: VEGFR1\2和3抑制剂 -
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂 -
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂 -
B7675 DIDSTarget: voltage-gated chloride channelsSummary: 阴离子运输抑制剂 -
B6367 NPPBTarget: Calcium-activated chloride channels (CaCC)|GPR35Summary: 氯离子通道抑制剂 -
B1439 Golvatinib (E7050)Target: VEGFRSummary: C-Met/VEGFR-2抑制剂 -
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂